Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$119.61 - $157.85 $1.42 Million - $1.88 Million
-11,900 Reduced 9.62%
111,800 $16.1 Million
Q4 2021

Feb 15, 2022

BUY
$142.57 - $190.86 $9.17 Million - $12.3 Million
64,300 Added 108.25%
123,700 $19.1 Million
Q3 2021

Nov 16, 2021

BUY
$142.45 - $169.82 $5.58 Million - $6.66 Million
39,200 Added 194.06%
59,400 $10.1 Million
Q2 2021

Aug 16, 2021

SELL
$135.08 - $161.1 $2.03 Million - $2.42 Million
-15,000 Reduced 42.61%
20,200 $3.19 Million
Q1 2021

May 18, 2021

SELL
$137.51 - $190.8 $2.78 Million - $3.85 Million
-20,200 Reduced 36.46%
35,200 $4.89 Million
Q4 2020

Feb 17, 2021

BUY
$164.63 - $211.93 $9.12 Million - $11.7 Million
55,400 New
55,400 $9.7 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.